Answers are grounded in this paper and cite their sources.
Analysis uncovers increased EGPA risk linked to leukotriene receptor antagonists, suggesting caution in clinical use.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: